Copeptin as a prognostic biomarker in acute myocardial infarction
Copeptin - the C-terminal section of vasopressin precursor - is a novel biomarker, that has been shown to be a useful prognostic factor in heart failure, ischemic stroke and in acute myocardial infarction (MI) but with restricted population and follow-up in ST-segment elevation MI (STEMI) setting. We evaluated in this study the hypothesis that copeptin measured on admission is an independent predictor of one-year all-cause mortality after a STEMI.
Source: International Journal of Cardiology - Category: Cardiology Authors: Benoit Lattuca, Vuthy Sy, Lee Nguyen, Maguy Bernard, Michel Zeitouni, Pavel Overtchouk, Yan Yan, Nadjib Hammoudi, Alexandre Ceccaldi, Jean-Philippe Collet, Mathieu Kerneis, Abdourahmane Diallo, Gilles Montalescot, Johanne Silvain Source Type: research